BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 30028248)

  • 1. Thymoquinone loaded in nanostructured lipid carrier showed enhanced anticancer activity in 4T1 tumor-bearing mice.
    Ong YS; Saiful Yazan L; Ng WK; Abdullah R; Mustapha NM; Sapuan S; Foo JB; Tor YS; How CW; Abd Rahman N; Zakarial Ansar FH
    Nanomedicine (Lond); 2018 Jul; 13(13):1567-1582. PubMed ID: 30028248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute and subacute toxicity profiles of thymoquinone-loaded nanostructured lipid carrier in BALB/c mice.
    Ong YS; Saiful Yazan L; Ng WK; Noordin MM; Sapuan S; Foo JB; Tor YS
    Int J Nanomedicine; 2016; 11():5905-5915. PubMed ID: 27877037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and Biodistribution of Thymoquinone-loaded Nanostructured Lipid Carrier After Oral and Intravenous Administration into Rats.
    Zakarial Ansar FH; Latifah SY; Wan Kamal WHB; Khong KC; Ng Y; Foong JN; Gopalsamy B; Ng WK; How CW; Ong YS; Abdullah R; Aziz MY
    Int J Nanomedicine; 2020; 15():7703-7717. PubMed ID: 33116496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thymoquinone-loaded nanostructured lipid carrier exhibited cytotoxicity towards breast cancer cell lines (MDA-MB-231 and MCF-7) and cervical cancer cell lines (HeLa and SiHa).
    Ng WK; Saiful Yazan L; Yap LH; Wan Nor Hafiza WA; How CW; Abdullah R
    Biomed Res Int; 2015; 2015():263131. PubMed ID: 25632388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma.
    El-Ashmawy NE; Khedr EG; Ebeid EM; Salem ML; Zidan AA; Mosalam EM
    Eur J Pharm Sci; 2017 Nov; 109():525-532. PubMed ID: 28890201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zerumbone-Loaded Nanostructured Lipid Carrier Induces Apoptosis of Canine Mammary Adenocarcinoma Cells.
    Foong JN; Selvarajah GT; Rasedee A; Rahman HS; How CW; Beh CY; Teo GY; Ku CL
    Biomed Res Int; 2018; 2018():8691569. PubMed ID: 30410940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular targeting of Akt by thymoquinone promotes G(1) arrest through translation inhibition of cyclin D1 and induces apoptosis in breast cancer cells.
    Rajput S; Kumar BN; Dey KK; Pal I; Parekh A; Mandal M
    Life Sci; 2013 Nov; 93(21):783-90. PubMed ID: 24044882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimization of Thymoquinone-Loaded Coconut Oil Nanostructured Lipid Carriers for the Management of Ethanol-Induced Ulcer.
    Fahmy UA; L Alaofi A; Awan ZA; Alqarni HM; Alhakamy NA
    AAPS PharmSciTech; 2020 May; 21(5):137. PubMed ID: 32419124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antitumor and Anti-Metastatic Effects of Citral-Loaded Nanostructured Lipid Carrier in 4T1-Induced Breast Cancer Mouse Model.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Mohamad NE; Abu N; Masarudin MJ; Abdullah R; Alitheen NB
    Molecules; 2020 Jun; 25(11):. PubMed ID: 32526880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The combination of thymoquinone and paclitaxel shows anti-tumor activity through the interplay with apoptosis network in triple-negative breast cancer.
    Şakalar Ç; İzgi K; İskender B; Sezen S; Aksu H; Çakır M; Kurt B; Turan A; Canatan H
    Tumour Biol; 2016 Apr; 37(4):4467-77. PubMed ID: 26500095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thymoquinone inhibits proliferation in gastric cancer via the STAT3 pathway in vivo and in vitro.
    Zhu WQ; Wang J; Guo XF; Liu Z; Dong WG
    World J Gastroenterol; 2016 Apr; 22(16):4149-59. PubMed ID: 27122665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thymoquinone enhances cisplatin-response through direct tumor effects in a syngeneic mouse model of ovarian cancer.
    Wilson AJ; Saskowski J; Barham W; Yull F; Khabele D
    J Ovarian Res; 2015 Jul; 8():46. PubMed ID: 26215403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded nanostructured lipid carrier induced apoptosis in human HepG2 cells through activation of the DR5/caspase-mediated extrinsic apoptosis pathway.
    Wang F; Ye X; Zhai D; Dai W; Wu Y; Chen J; Chen W
    Acta Pharm; 2020 Jun; 70(2):227-237. PubMed ID: 31955141
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thymoquinone Enhances Paclitaxel Anti-Breast Cancer Activity via Inhibiting Tumor-Associated Stem Cells Despite Apparent Mathematical Antagonism.
    Bashmail HA; Alamoudi AA; Noorwali A; Hegazy GA; Ajabnoor GM; Al-Abd AM
    Molecules; 2020 Jan; 25(2):. PubMed ID: 31968657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro cytotoxicity and anticancer effects of citral nanostructured lipid carrier on MDA MBA-231 human breast cancer cells.
    Nordin N; Yeap SK; Rahman HS; Zamberi NR; Abu N; Mohamad NE; How CW; Masarudin MJ; Abdullah R; Alitheen NB
    Sci Rep; 2019 Feb; 9(1):1614. PubMed ID: 30733560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticancer activity of thymoquinone in breast cancer cells: possible involvement of PPAR-γ pathway.
    Woo CC; Loo SY; Gee V; Yap CW; Sethi G; Kumar AP; Tan KH
    Biochem Pharmacol; 2011 Sep; 82(5):464-75. PubMed ID: 21679698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thymoquinone from Nigella sativa was more potent than cisplatin in eliminating of SiHa cells via apoptosis with down-regulation of Bcl-2 protein.
    Ng WK; Yazan LS; Ismail M
    Toxicol In Vitro; 2011 Oct; 25(7):1392-8. PubMed ID: 21609759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymoquinone as an anticancer agent: evidence from inhibition of cancer cells viability and invasion in vitro and tumor growth in vivo.
    Attoub S; Sperandio O; Raza H; Arafat K; Al-Salam S; Al Sultan MA; Al Safi M; Takahashi T; Adem A
    Fundam Clin Pharmacol; 2013 Oct; 27(5):557-69. PubMed ID: 22788741
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TQ inhibits hepatocellular carcinoma growth in vitro and in vivo via repression of Notch signaling.
    Ke X; Zhao Y; Lu X; Wang Z; Liu Y; Ren M; Lu G; Zhang D; Sun Z; Xu Z; Song JH; Cheng Y; Meltzer SJ; He S
    Oncotarget; 2015 Oct; 6(32):32610-21. PubMed ID: 26416455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of Bioavailability and Pharmacodynamic Effects of Thymoquinone Via Nanostructured Lipid Carrier (NLC) Formulation.
    Elmowafy M; Samy A; Raslan MA; Salama A; Said RA; Abdelaziz AE; El-Eraky W; El Awdan S; Viitala T
    AAPS PharmSciTech; 2016 Jun; 17(3):663-72. PubMed ID: 26304932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.